CONCURRENT CONTROLS USED IN 50-60% OF DEVICE TRIALS, FDA'S BURLINGTON SAYS
This article was originally published in The Gray Sheet
Executive Summary
More than half of medical device clinical trials currently being conducted employ concurrent controls, Center for Devices and Radiological Health Director Bruce Burlington said Sept. 10 at the Regulatory Affairs Professionals Society annual meeting in Washington, D.C.